Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
PaperCitations, authors & open-access status
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 415 citations, 2021 year and green oa status.
415
Citations
2021
Year
green
OA Status